CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of -$2.66 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was -$2.66M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|---|
| 2025-12-27 | -$2.66M 10-K · filed 2026-02-18 | |
| 2016-09-24 | $10.40M 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |